ETS1 (ETS proto-oncogene 1) is a transcription factor that plays diverse roles in cellular homeostasis and disease pathogenesis. ETS1 functions as a DNA-binding transcription factor that regulates gene expression through RNA polymerase II-mediated transcription 1. The protein governs pathological tissue-remodeling programs in disease-associated fibroblasts, particularly in autoimmune arthritis where it drives polarization toward tissue-destructive phenotypes by orchestrating regulatory elements of RANKL and matrix metalloproteinases 2. ETS1 demonstrates protective functions in several contexts: it ameliorates hyperoxia-induced bronchopulmonary dysplasia by activating the Nrf2/HO-1 pathway to suppress ferroptosis 3, and transcriptionally regulates METTL14 to suppress TGF-β1-induced epithelial-mesenchymal transition in bronchial epithelial cells 1. However, ETS1 can also promote pathological processes, including sorafenib resistance in hepatocellular carcinoma through miR-23a-3p-mediated suppression of ferroptosis 4 and endothelial dysfunction in sepsis by facilitating mtDNA release via VDAC1 oligomerization 5. Post-translational modifications regulate ETS1 activity, including deacetylation by HDAC8 that enhances its interaction with HIF-2α in renal cell carcinoma 6. These findings highlight ETS1's context-dependent roles in both protective and pathogenic cellular programs.